AstraZeneca vaccine approval unlikely in January: EU
An undated handout picture released on November 23, 2020 shows a vial of the Covid-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech, in partnership with pharmaceutical giant AstraZeneca.
Photo credit: John Cairns | University of Oxford | AFP
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
